0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Rapid Antimicrobial Susceptibility Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-22F13903
Home | Market Reports | Health| Medical Devices & Equipment
Global Rapid Antimicrobial Susceptibility Testing Market Research Report 2023
BUY CHAPTERS

Rapid Antimicrobial Susceptibility Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-22F13903
Report
October 2024
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rapid Antimicrobial Susceptibility Testing - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rapid Antimicrobial Susceptibility Testing - Market

Rapid Antimicrobial Susceptibility Testing - Market

Susceptibility testing is used to determine which antimicrobials will inhibit the growth of the bacteria or fungi causing a specific infection.
The global market for Rapid Antimicrobial Susceptibility Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rapid Antimicrobial Susceptibility Testing, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rapid Antimicrobial Susceptibility Testing by region & country, by Type, and by Application.
The Rapid Antimicrobial Susceptibility Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antimicrobial Susceptibility Testing.
Market Segmentation

Scope of Rapid Antimicrobial Susceptibility Testing - Market Report

Report Metric Details
Report Name Rapid Antimicrobial Susceptibility Testing - Market
CAGR 5%
Segment by Type:
  • Antibacterial Susceptibility Testing
  • Antifungal Susceptibility Testing
  • Antiparasitic Susceptibility Testing
  • Others
Segment by Application
  • Clinical Diagnostics
  • Drug Development
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMérieux, BD, Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics, Merck, HiMedia Laboratories, Liofilchem S.R.L Diagnostics, Alifax S.r.l., Creative Diagnostics, Synbiosis, Bioanalyse, ZHUHAI DL BIOTECH, ELITechGroup, Mast Group, CONDALAB, Genefluidics, Biotron, InvivoGen, MP Biomedicals, QuantaMatrix, PML Microbiologicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Rapid Antimicrobial Susceptibility Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Rapid Antimicrobial Susceptibility Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Rapid Antimicrobial Susceptibility Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Rapid Antimicrobial Susceptibility Testing - Market report?

Ans: The main players in the Rapid Antimicrobial Susceptibility Testing - Market are BioMérieux, BD, Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics, Merck, HiMedia Laboratories, Liofilchem S.R.L Diagnostics, Alifax S.r.l., Creative Diagnostics, Synbiosis, Bioanalyse, ZHUHAI DL BIOTECH, ELITechGroup, Mast Group, CONDALAB, Genefluidics, Biotron, InvivoGen, MP Biomedicals, QuantaMatrix, PML Microbiologicals

What are the Application segmentation covered in the Rapid Antimicrobial Susceptibility Testing - Market report?

Ans: The Applications covered in the Rapid Antimicrobial Susceptibility Testing - Market report are Clinical Diagnostics, Drug Development, Other

What are the Type segmentation covered in the Rapid Antimicrobial Susceptibility Testing - Market report?

Ans: The Types covered in the Rapid Antimicrobial Susceptibility Testing - Market report are Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, Others

1 Market Overview
1.1 Rapid Antimicrobial Susceptibility Testing Product Introduction
1.2 Global Rapid Antimicrobial Susceptibility Testing Market Size Forecast
1.2.1 Global Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030)
1.2.2 Global Rapid Antimicrobial Susceptibility Testing Sales Volume (2019-2030)
1.2.3 Global Rapid Antimicrobial Susceptibility Testing Sales Price (2019-2030)
1.3 Rapid Antimicrobial Susceptibility Testing Market Trends & Drivers
1.3.1 Rapid Antimicrobial Susceptibility Testing Industry Trends
1.3.2 Rapid Antimicrobial Susceptibility Testing Market Drivers & Opportunity
1.3.3 Rapid Antimicrobial Susceptibility Testing Market Challenges
1.3.4 Rapid Antimicrobial Susceptibility Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rapid Antimicrobial Susceptibility Testing Players Revenue Ranking (2023)
2.2 Global Rapid Antimicrobial Susceptibility Testing Revenue by Company (2019-2024)
2.3 Global Rapid Antimicrobial Susceptibility Testing Players Sales Volume Ranking (2023)
2.4 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Company Players (2019-2024)
2.5 Global Rapid Antimicrobial Susceptibility Testing Average Price by Company (2019-2024)
2.6 Key Manufacturers Rapid Antimicrobial Susceptibility Testing Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Rapid Antimicrobial Susceptibility Testing Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Rapid Antimicrobial Susceptibility Testing
2.9 Rapid Antimicrobial Susceptibility Testing Market Competitive Analysis
2.9.1 Rapid Antimicrobial Susceptibility Testing Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Rapid Antimicrobial Susceptibility Testing Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antimicrobial Susceptibility Testing as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibacterial Susceptibility Testing
3.1.2 Antifungal Susceptibility Testing
3.1.3 Antiparasitic Susceptibility Testing
3.1.4 Others
3.2 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Type
3.2.1 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rapid Antimicrobial Susceptibility Testing Sales Value, by Type (2019-2030)
3.2.3 Global Rapid Antimicrobial Susceptibility Testing Sales Value, by Type (%) (2019-2030)
3.3 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Type
3.3.1 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Rapid Antimicrobial Susceptibility Testing Sales Volume, by Type (2019-2030)
3.3.3 Global Rapid Antimicrobial Susceptibility Testing Sales Volume, by Type (%) (2019-2030)
3.4 Global Rapid Antimicrobial Susceptibility Testing Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Diagnostics
4.1.2 Drug Development
4.1.3 Other
4.2 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Application
4.2.1 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rapid Antimicrobial Susceptibility Testing Sales Value, by Application (2019-2030)
4.2.3 Global Rapid Antimicrobial Susceptibility Testing Sales Value, by Application (%) (2019-2030)
4.3 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Application
4.3.1 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Rapid Antimicrobial Susceptibility Testing Sales Volume, by Application (2019-2030)
4.3.3 Global Rapid Antimicrobial Susceptibility Testing Sales Volume, by Application (%) (2019-2030)
4.4 Global Rapid Antimicrobial Susceptibility Testing Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region
5.1.1 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024)
5.1.3 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030)
5.1.4 Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (%), (2019-2030)
5.2 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region
5.2.1 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (2019-2024)
5.2.3 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (2025-2030)
5.2.4 Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (%), (2019-2030)
5.3 Global Rapid Antimicrobial Susceptibility Testing Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.4.2 North America Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.5.2 Europe Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.6.2 Asia Pacific Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.7.2 South America Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.8.2 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value
6.2.1 Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.2.2 Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.3.2 United States Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.4.2 Europe Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.5.2 China Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.6.2 Japan Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.7.2 South Korea Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rapid Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.9.2 India Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rapid Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioMérieux
7.1.1 BioMérieux Company Information
7.1.2 BioMérieux Introduction and Business Overview
7.1.3 BioMérieux Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.1.4 BioMérieux Rapid Antimicrobial Susceptibility Testing Product Offerings
7.1.5 BioMérieux Recent Development
7.2 BD
7.2.1 BD Company Information
7.2.2 BD Introduction and Business Overview
7.2.3 BD Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BD Rapid Antimicrobial Susceptibility Testing Product Offerings
7.2.5 BD Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Information
7.3.2 Thermo Fisher Scientific Introduction and Business Overview
7.3.3 Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Product Offerings
7.3.5 Thermo Fisher Scientific Recent Development
7.4 Danaher
7.4.1 Danaher Company Information
7.4.2 Danaher Introduction and Business Overview
7.4.3 Danaher Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Danaher Rapid Antimicrobial Susceptibility Testing Product Offerings
7.4.5 Danaher Recent Development
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Information
7.5.2 Bio-Rad Laboratories Introduction and Business Overview
7.5.3 Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Product Offerings
7.5.5 Bio-Rad Laboratories Recent Development
7.6 Bruker
7.6.1 Bruker Company Information
7.6.2 Bruker Introduction and Business Overview
7.6.3 Bruker Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bruker Rapid Antimicrobial Susceptibility Testing Product Offerings
7.6.5 Bruker Recent Development
7.7 Roche Diagnostics
7.7.1 Roche Diagnostics Company Information
7.7.2 Roche Diagnostics Introduction and Business Overview
7.7.3 Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
7.7.5 Roche Diagnostics Recent Development
7.8 Accelerate Diagnostics
7.8.1 Accelerate Diagnostics Company Information
7.8.2 Accelerate Diagnostics Introduction and Business Overview
7.8.3 Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
7.8.5 Accelerate Diagnostics Recent Development
7.9 Merck
7.9.1 Merck Company Information
7.9.2 Merck Introduction and Business Overview
7.9.3 Merck Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck Rapid Antimicrobial Susceptibility Testing Product Offerings
7.9.5 Merck Recent Development
7.10 HiMedia Laboratories
7.10.1 HiMedia Laboratories Company Information
7.10.2 HiMedia Laboratories Introduction and Business Overview
7.10.3 HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.10.4 HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Product Offerings
7.10.5 HiMedia Laboratories Recent Development
7.11 Liofilchem S.R.L Diagnostics
7.11.1 Liofilchem S.R.L Diagnostics Company Information
7.11.2 Liofilchem S.R.L Diagnostics Introduction and Business Overview
7.11.3 Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
7.11.5 Liofilchem S.R.L Diagnostics Recent Development
7.12 Alifax S.r.l.
7.12.1 Alifax S.r.l. Company Information
7.12.2 Alifax S.r.l. Introduction and Business Overview
7.12.3 Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Product Offerings
7.12.5 Alifax S.r.l. Recent Development
7.13 Creative Diagnostics
7.13.1 Creative Diagnostics Company Information
7.13.2 Creative Diagnostics Introduction and Business Overview
7.13.3 Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
7.13.5 Creative Diagnostics Recent Development
7.14 Synbiosis
7.14.1 Synbiosis Company Information
7.14.2 Synbiosis Introduction and Business Overview
7.14.3 Synbiosis Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Synbiosis Rapid Antimicrobial Susceptibility Testing Product Offerings
7.14.5 Synbiosis Recent Development
7.15 Bioanalyse
7.15.1 Bioanalyse Company Information
7.15.2 Bioanalyse Introduction and Business Overview
7.15.3 Bioanalyse Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Bioanalyse Rapid Antimicrobial Susceptibility Testing Product Offerings
7.15.5 Bioanalyse Recent Development
7.16 ZHUHAI DL BIOTECH
7.16.1 ZHUHAI DL BIOTECH Company Information
7.16.2 ZHUHAI DL BIOTECH Introduction and Business Overview
7.16.3 ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.16.4 ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Product Offerings
7.16.5 ZHUHAI DL BIOTECH Recent Development
7.17 ELITechGroup
7.17.1 ELITechGroup Company Information
7.17.2 ELITechGroup Introduction and Business Overview
7.17.3 ELITechGroup Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.17.4 ELITechGroup Rapid Antimicrobial Susceptibility Testing Product Offerings
7.17.5 ELITechGroup Recent Development
7.18 Mast Group
7.18.1 Mast Group Company Information
7.18.2 Mast Group Introduction and Business Overview
7.18.3 Mast Group Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Mast Group Rapid Antimicrobial Susceptibility Testing Product Offerings
7.18.5 Mast Group Recent Development
7.19 CONDALAB
7.19.1 CONDALAB Company Information
7.19.2 CONDALAB Introduction and Business Overview
7.19.3 CONDALAB Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.19.4 CONDALAB Rapid Antimicrobial Susceptibility Testing Product Offerings
7.19.5 CONDALAB Recent Development
7.20 Genefluidics
7.20.1 Genefluidics Company Information
7.20.2 Genefluidics Introduction and Business Overview
7.20.3 Genefluidics Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Genefluidics Rapid Antimicrobial Susceptibility Testing Product Offerings
7.20.5 Genefluidics Recent Development
7.21 Biotron
7.21.1 Biotron Company Information
7.21.2 Biotron Introduction and Business Overview
7.21.3 Biotron Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Biotron Rapid Antimicrobial Susceptibility Testing Product Offerings
7.21.5 Biotron Recent Development
7.22 InvivoGen
7.22.1 InvivoGen Company Information
7.22.2 InvivoGen Introduction and Business Overview
7.22.3 InvivoGen Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.22.4 InvivoGen Rapid Antimicrobial Susceptibility Testing Product Offerings
7.22.5 InvivoGen Recent Development
7.23 MP Biomedicals
7.23.1 MP Biomedicals Company Information
7.23.2 MP Biomedicals Introduction and Business Overview
7.23.3 MP Biomedicals Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.23.4 MP Biomedicals Rapid Antimicrobial Susceptibility Testing Product Offerings
7.23.5 MP Biomedicals Recent Development
7.24 QuantaMatrix
7.24.1 QuantaMatrix Company Information
7.24.2 QuantaMatrix Introduction and Business Overview
7.24.3 QuantaMatrix Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.24.4 QuantaMatrix Rapid Antimicrobial Susceptibility Testing Product Offerings
7.24.5 QuantaMatrix Recent Development
7.25 PML Microbiologicals
7.25.1 PML Microbiologicals Company Information
7.25.2 PML Microbiologicals Introduction and Business Overview
7.25.3 PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Sales, Revenue and Gross Margin (2019-2024)
7.25.4 PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Product Offerings
7.25.5 PML Microbiologicals Recent Development
8 Industry Chain Analysis
8.1 Rapid Antimicrobial Susceptibility Testing Industrial Chain
8.2 Rapid Antimicrobial Susceptibility Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rapid Antimicrobial Susceptibility Testing Sales Model
8.5.2 Sales Channel
8.5.3 Rapid Antimicrobial Susceptibility Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Rapid Antimicrobial Susceptibility Testing Market Trends
    Table 2. Rapid Antimicrobial Susceptibility Testing Market Drivers & Opportunity
    Table 3. Rapid Antimicrobial Susceptibility Testing Market Challenges
    Table 4. Rapid Antimicrobial Susceptibility Testing Market Restraints
    Table 5. Global Rapid Antimicrobial Susceptibility Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Company (2019-2024)
    Table 7. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Rapid Antimicrobial Susceptibility Testing Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Rapid Antimicrobial Susceptibility Testing Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Rapid Antimicrobial Susceptibility Testing Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Rapid Antimicrobial Susceptibility Testing Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Rapid Antimicrobial Susceptibility Testing
    Table 13. Global Rapid Antimicrobial Susceptibility Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antimicrobial Susceptibility Testing as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Rapid Antimicrobial Susceptibility Testing Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Rapid Antimicrobial Susceptibility Testing Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Rapid Antimicrobial Susceptibility Testing Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Rapid Antimicrobial Susceptibility Testing Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Rapid Antimicrobial Susceptibility Testing Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024) & (%)
    Table 44. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030) & (%)
    Table 45. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Rapid Antimicrobial Susceptibility Testing Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Rapid Antimicrobial Susceptibility Testing Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Volume, (2025-2030) & (K Units)
    Table 57. BioMérieux Company Information
    Table 58. BioMérieux Introduction and Business Overview
    Table 59. BioMérieux Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. BioMérieux Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 61. BioMérieux Recent Development
    Table 62. BD Company Information
    Table 63. BD Introduction and Business Overview
    Table 64. BD Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. BD Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 66. BD Recent Development
    Table 67. Thermo Fisher Scientific Company Information
    Table 68. Thermo Fisher Scientific Introduction and Business Overview
    Table 69. Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 71. Thermo Fisher Scientific Recent Development
    Table 72. Danaher Company Information
    Table 73. Danaher Introduction and Business Overview
    Table 74. Danaher Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Danaher Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 76. Danaher Recent Development
    Table 77. Bio-Rad Laboratories Company Information
    Table 78. Bio-Rad Laboratories Introduction and Business Overview
    Table 79. Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 81. Bio-Rad Laboratories Recent Development
    Table 82. Bruker Company Information
    Table 83. Bruker Introduction and Business Overview
    Table 84. Bruker Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Bruker Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 86. Bruker Recent Development
    Table 87. Roche Diagnostics Company Information
    Table 88. Roche Diagnostics Introduction and Business Overview
    Table 89. Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 91. Roche Diagnostics Recent Development
    Table 92. Accelerate Diagnostics Company Information
    Table 93. Accelerate Diagnostics Introduction and Business Overview
    Table 94. Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 96. Accelerate Diagnostics Recent Development
    Table 97. Merck Company Information
    Table 98. Merck Introduction and Business Overview
    Table 99. Merck Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Merck Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 101. Merck Recent Development
    Table 102. HiMedia Laboratories Company Information
    Table 103. HiMedia Laboratories Introduction and Business Overview
    Table 104. HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 106. HiMedia Laboratories Recent Development
    Table 107. Liofilchem S.R.L Diagnostics Company Information
    Table 108. Liofilchem S.R.L Diagnostics Introduction and Business Overview
    Table 109. Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 111. Liofilchem S.R.L Diagnostics Recent Development
    Table 112. Alifax S.r.l. Company Information
    Table 113. Alifax S.r.l. Introduction and Business Overview
    Table 114. Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 116. Alifax S.r.l. Recent Development
    Table 117. Creative Diagnostics Company Information
    Table 118. Creative Diagnostics Introduction and Business Overview
    Table 119. Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 121. Creative Diagnostics Recent Development
    Table 122. Synbiosis Company Information
    Table 123. Synbiosis Introduction and Business Overview
    Table 124. Synbiosis Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Synbiosis Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 126. Synbiosis Recent Development
    Table 127. Bioanalyse Company Information
    Table 128. Bioanalyse Introduction and Business Overview
    Table 129. Bioanalyse Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Bioanalyse Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 131. Bioanalyse Recent Development
    Table 132. ZHUHAI DL BIOTECH Company Information
    Table 133. ZHUHAI DL BIOTECH Introduction and Business Overview
    Table 134. ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 136. ZHUHAI DL BIOTECH Recent Development
    Table 137. ELITechGroup Company Information
    Table 138. ELITechGroup Introduction and Business Overview
    Table 139. ELITechGroup Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. ELITechGroup Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 141. ELITechGroup Recent Development
    Table 142. Mast Group Company Information
    Table 143. Mast Group Introduction and Business Overview
    Table 144. Mast Group Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Mast Group Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 146. Mast Group Recent Development
    Table 147. CONDALAB Company Information
    Table 148. CONDALAB Introduction and Business Overview
    Table 149. CONDALAB Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. CONDALAB Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 151. CONDALAB Recent Development
    Table 152. Genefluidics Company Information
    Table 153. Genefluidics Introduction and Business Overview
    Table 154. Genefluidics Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Genefluidics Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 156. Genefluidics Recent Development
    Table 157. Biotron Company Information
    Table 158. Biotron Introduction and Business Overview
    Table 159. Biotron Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Biotron Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 161. Biotron Recent Development
    Table 162. InvivoGen Company Information
    Table 163. InvivoGen Introduction and Business Overview
    Table 164. InvivoGen Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. InvivoGen Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 166. InvivoGen Recent Development
    Table 167. MP Biomedicals Company Information
    Table 168. MP Biomedicals Introduction and Business Overview
    Table 169. MP Biomedicals Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. MP Biomedicals Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 171. MP Biomedicals Recent Development
    Table 172. QuantaMatrix Company Information
    Table 173. QuantaMatrix Introduction and Business Overview
    Table 174. QuantaMatrix Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. QuantaMatrix Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 176. QuantaMatrix Recent Development
    Table 177. PML Microbiologicals Introduction and Business Overview
    Table 178. PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 179. PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Product Offerings
    Table 180. PML Microbiologicals Recent Development
    Table 181. PML Microbiologicals Company Information
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Rapid Antimicrobial Susceptibility Testing Downstream Customers
    Table 185. Rapid Antimicrobial Susceptibility Testing Distributors List
    Table 186. Research Programs/Design for This Report
    Table 187. Key Data Information from Secondary Sources
    Table 188. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rapid Antimicrobial Susceptibility Testing Product Picture
    Figure 2. Global Rapid Antimicrobial Susceptibility Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Rapid Antimicrobial Susceptibility Testing Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Rapid Antimicrobial Susceptibility Testing Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Rapid Antimicrobial Susceptibility Testing Report Years Considered
    Figure 7. Global Rapid Antimicrobial Susceptibility Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Rapid Antimicrobial Susceptibility Testing Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rapid Antimicrobial Susceptibility Testing Revenue in 2023
    Figure 10. Rapid Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Antibacterial Susceptibility Testing Picture
    Figure 12. Antifungal Susceptibility Testing Picture
    Figure 13. Antiparasitic Susceptibility Testing Picture
    Figure 14. Others Picture
    Figure 15. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Rapid Antimicrobial Susceptibility Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Rapid Antimicrobial Susceptibility Testing Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Rapid Antimicrobial Susceptibility Testing Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Clinical Diagnostics
    Figure 21. Product Picture of Drug Development
    Figure 22. Product Picture of Other
    Figure 23. Global Rapid Antimicrobial Susceptibility Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Rapid Antimicrobial Susceptibility Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Rapid Antimicrobial Susceptibility Testing Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Rapid Antimicrobial Susceptibility Testing Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Rapid Antimicrobial Susceptibility Testing Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Rapid Antimicrobial Susceptibility Testing Sales Volume (%), (2019-2030)
    Figure 40. United States Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Rapid Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Rapid Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Rapid Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
    Figure 61. Rapid Antimicrobial Susceptibility Testing Industrial Chain
    Figure 62. Rapid Antimicrobial Susceptibility Testing Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Animal Nerve Stimulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-27Q18371
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Absorbable Microneedles - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-8V15090
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Medical Heat Shrinkable Tubing Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-28O7342
Thu Dec 12 00:00:00 UTC 2024

Add to Cart